[Critical comments on the contribution by B. Warkentin: "Late gestosis as a compensation mechanisms in intrauterine growth retardation and the effect of blood pressure lowering therapy"].
D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology*; D005260:Female; D005317:Fetal Growth Retardation / Q000503:physiopathology*; D006801:Humans; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange / Q000187:drug effects / Q000502:physiology*; D011225:Pre-Eclampsia / Q000188:drug therapy / Q000503:physiopathology*; D011247:Pregnancy; D012307:Risk Factors
D000959:Antihypertensive Agents
Kritische Bemerkung zum Beitrag von B. Warkentin: "Die Spätgestose als Kompensations-Mechanismus bei fetaler Mangelentwicklung und seine Störung durch blutdrucksenkende Therapie".